Amyris Inc
F:3A01
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telia Company AB
STO:TELIA
|
SE |
|
Dafeng TV Ltd
TWSE:6184
|
TW |
Amyris Inc
Common Stock
Amyris Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amyris Inc
F:3A01
|
Common Stock
$36k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Common Stock
$83.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Common Stock
$4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Common Stock
$369.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Common Stock
$969m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Albemarle Corp
NYSE:ALB
|
Common Stock
$2.2B
|
CAGR 3-Years
1 208%
|
CAGR 5-Years
368%
|
CAGR 10-Years
116%
|
|
Amyris Inc
Glance View
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
See Also
What is Amyris Inc's Common Stock?
Common Stock
36k
USD
Based on the financial report for Dec 31, 2022, Amyris Inc's Common Stock amounts to 36k USD.
What is Amyris Inc's Common Stock growth rate?
Common Stock CAGR 1Y
16%
Over the last year, the Common Stock growth was 16%.
